Icosavax Balance Sheet Health
Financial Health criteria checks 6/6
Icosavax has a total shareholder equity of $232.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $251.3M and $18.9M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$229.21m |
Equity | US$232.38m |
Total liabilities | US$18.92m |
Total assets | US$251.30m |
Recent financial health updates
We Think Icosavax (NASDAQ:ICVX) Can Afford To Drive Business Growth
Jul 04Will Icosavax (NASDAQ:ICVX) Spend Its Cash Wisely?
Mar 10Is Icosavax (NASDAQ:ICVX) In A Good Position To Invest In Growth?
Oct 18Here's Why We're Not Too Worried About Icosavax's (NASDAQ:ICVX) Cash Burn Situation
Jun 22Recent updates
We Think Icosavax (NASDAQ:ICVX) Can Afford To Drive Business Growth
Jul 04Will Icosavax (NASDAQ:ICVX) Spend Its Cash Wisely?
Mar 10Is Icosavax (NASDAQ:ICVX) In A Good Position To Invest In Growth?
Oct 18Icosavax GAAP EPS of -$0.57
Aug 15Icosavax to pursue COVID bivalent vaccine in 2023 as biotech highlights near-term milestones
Jul 28Here's Why We're Not Too Worried About Icosavax's (NASDAQ:ICVX) Cash Burn Situation
Jun 22Here's Why We're Not Too Worried About Icosavax's (NASDAQ:ICVX) Cash Burn Situation
Mar 24We're Hopeful That Icosavax (NASDAQ:ICVX) Will Use Its Cash Wisely
Oct 29Financial Position Analysis
Short Term Liabilities: ICVX's short term assets ($235.3M) exceed its short term liabilities ($13.0M).
Long Term Liabilities: ICVX's short term assets ($235.3M) exceed its long term liabilities ($5.9M).
Debt to Equity History and Analysis
Debt Level: ICVX is debt free.
Reducing Debt: ICVX had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ICVX has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: ICVX has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 51.6% each year.